Sumedha Sudhaman

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma.

Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma.

Journal: Cancers

Published: October 16, 2025

Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma.

Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 02, 2025

Delineation and monitoring of the T cell repertoire of adoptive cell transfer product during the treatment of advanced melanoma.

Delineation and monitoring of the T cell repertoire of adoptive cell transfer product during the treatment of advanced melanoma.

Journal: Genome medicine

Published: December 30, 2024

Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell Carcinoma.

Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell Carcinoma.

Journal: JCO precision oncology

Published: December 18, 2024

Neoadjuvant and Adjuvant Osimertinib in Stage IA to IIIA, EGFR-Mutant NSCLC (NORA).

Neoadjuvant and Adjuvant Osimertinib in Stage IA to IIIA, EGFR-Mutant NSCLC (NORA).

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: November 20, 2024

Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study.

Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study.

Journal: JTO clinical and research reports

Published: August 14, 2024

Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinoma.

Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinoma.

Journal: The oncologist

Published: February 20, 2024

Personalized, tumor-informed, circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients receiving curative treatments.

Personalized, tumor-informed, circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients receiving curative treatments.

Journal: Thoracic cancer

Published: January 07, 2024

Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancer.

Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancer.

Journal: Cancer

Published: September 28, 2023

Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Malignancies.

Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Malignancies.

Journal: JCO precision oncology

Published: July 19, 2023

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.

Journal: Frontiers in oncology

Published: July 05, 2023

Biallelic EPCAM deletions induce tissue-specific DNA repair deficiency and cancer predisposition.

Biallelic EPCAM deletions induce tissue-specific DNA repair deficiency and cancer predisposition.

Journal: NPJ precision oncology

Published: June 28, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026